A patient with a history of rapid-cycling bipolar disorder presents for evaluation of her current, profound depressive symptoms. The patient has been maintained for the last two years on valproic acid and quetiapine, but now a major depressive episode has occurred and the patient is reporting passive suicidal ideation.

Concerned that the suicidal ideation may progress, the PMHNP consider which of the following pharmacotherapeutic options?

A. Cariprazine

B. Lumateperone

C. Aripiprazole

D. Lithium

The PMHNP is seeing a patient who presents for complaint of depressive symptoms. The patient reports a history of anhedonia, hopelessness, worthlessness, sleep dysfunction, marked decrease in appetite with an unplanned 5 lb wt loss in the last month, and a marked inability to concentrate on necessary tasks.

Before diagnosing the patient with major depressive disorder and beginning antidepressive therapy, the PMHNP should:

A. Document a Patient Health Questionnaire-9

B. Administer a Mood Disorder Questionnaire

C. Refer the patient to cognitive behavioral therapy

D. Order a TSH and a CBC to rule out physiologic causes

The PMHNP has a new patient who reminds her of a former teacher who played an important role in her life and whom she regards as a mentor. The NP is concerned that she may express countertransference and is especially watchful for all of the following except:

A. Resistance and strong emotion from the patient

B. Dreaming about the patient

C. Extending appointments beyond normal time frame

D. Offering small, inexpensive gifts occasionally to the patient